List of SBIR/STTR awards granted to Fox Chase Chemical Diversity Center Inc.
A SBIR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in September, 2018 for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in September, 2019 for $999,945.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in July, 2020 for $306,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in August, 2022 for $306,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in July, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in August, 2022 for $306,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in July, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in July, 2018 for $300,002.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in May, 2020 for $309,102.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in April, 2021 for $306,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in April, 2021 for $1,017,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in September, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in June, 2022 for $1,050,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in June, 2018 for $597,435.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in May, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in September, 2017 for $1,499,687.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in April, 2016 for $3,002,878.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in March, 2015 for $300,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in August, 2016 for $1,942,140.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in July, 2014 for $1,500,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Fox Chase Chemical Diversity Center Inc. in January, 2015 for $2,307,830.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in April, 2015 for $300,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in April, 2017 for $300,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in April, 2017 for $300,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Fox Chase Chemical Diversity Center Inc. in March, 2017 for $299,999.0 USD from the U.S. Department of Health & Human Services.
